ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 258168 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 258168; 2) Community: the network communities that were significantly associated with the response to NSC 258168; 3) Molecule: the relationships between components within communities and NSC 258168; 4) MDR: the compounds that were significantly associated with the NSC 258168.

NSC Compound Enrichment Correlation
NSC 734307 3,4-Dihydroxy-N(3-O-methyl-estra-1,3,5(10)-trien-ol-17b-yl)c innamide 0.0352383000003056 0.29979348
NSC 737342 6-(3-Azidopropyl)-5,6-dihydro-2,3,9-trimethoxy-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline 0.0352383000003056 -0.073875465
NSC 743396 Null 0.0352383000003056 0.42025155
NSC 743691 Null 0.0352383000003056 0.31083724
NSC 750324 Null 0.0352383000003056 0.38305166
NSC 751393 2-(4,5-dibenzoyl-1,3-dithiol-2-ylidene)-1-ethyl-6-(phenylimino)-3-thioxo-2,3-dihydro-1H-thieno[2,3-b][1,4]thiazin-7(6H)-one 0.0352383000003056 0.58731145
NSC 757113 METHOTREXATE(+/-) 0.0352383000003056 0.22152533
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0352383000003058 0.12622798
NSC 1390 Allopurinol 0.0352383000003058 0.0051034899
NSC 142493 Null 0.0352383000003058 0.09444659
Total:84  Current:62    [First] [Prev] [Next] [Last]